» Articles » PMID: 38595874

Mycobacterium Porcinum Disseminated Infection in Non-severely Immunocompromised Host

Overview
Journal Cureus
Date 2024 Apr 10
PMID 38595874
Authors
Affiliations
Soon will be listed here.
Abstract

 is a nontuberculous mycobacteria (NTM) recently identified to cause human infection. Correct speciation of NTMs can be difficult and result in misdiagnosis and delayed treatment. Because of the paucity of the literature, there is a lack of awareness of the possibility of serious infections caused by . Although severe infections tend to occur in individuals with certain risk factors, the primary being an immunocompromised state, our case illustrates that it can also be possible in non-severely immunocompromised individuals. A 65-year-old male with a medical history of diabetes mellitus (DM), end-stage renal disease (ESRD) on hemodialysis (HD), congestive heart failure (CHF), and chronic obstructive pulmonary disease (COPD) was admitted to the emergency room due to a laceration on his right lower leg following a fall. He reported shortness of breath but denied other respiratory symptoms. On examination, he showed signs of infection and increased oxygen requirement compared to baseline. Blood culture was positive for acid-fast bacilli (AFB), initially reported as  (MAC) and later confirmed as  through gene sequencing and morphology analysis. Interval blood cultures taken a week later confirmed true  bacteremia. Treatment initially involved intravenous antibiotics- imipenem and ciprofloxacin before transitioning to oral linezolid and ciprofloxacin based on sensitivities. Following 10 days of antibiotic therapy, subsequent blood cultures returned negative, and treatment with oral antibiotics was advised, with continued outpatient follow-up with infectious disease in two weeks. , typically considered a contaminant in healthy individuals, was identified as the causative agent of a disseminated infection in a non-severely immunocompromised patient. This case underscores the importance of accurately identifying the specific mycobacterial species, confirming true infection, and conducting antibiotic susceptibility testing due to the distinct antibiotic susceptibility profile of  compared to other NTM like MAC.

References
1.
Wallace Jr R, Brown-Elliott B, Wilson R, Mann L, Hall L, Zhang Y . Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol. 2004; 42(12):5689-97. PMC: 535230. DOI: 10.1128/JCM.42.12.5689-5697.2004. View

2.
Bonura C, Di Carlo P, Spicola D, Cal C, Mammina C, Fasciana T . Rapidly growing mycobacteria in TB/HIV co-infection: a report of two cases focusing on difficulties in diagnosis and management. New Microbiol. 2012; 35(2):239-43. View

3.
Jarchow-MacDonald A, Smith M, Seagar A, Russell C, Claxton P, Laurenson I . Changing Incidence and Characteristics of Nontuberculous Mycobacterial Infections in Scotland and Comparison With Complex Incidence (2011 to 2019). Open Forum Infect Dis. 2023; 10(1):ofac665. PMC: 9879710. DOI: 10.1093/ofid/ofac665. View

4.
Brown-Elliott B, Wallace Jr R, Tichindelean C, Sarria J, McNulty S, Vasireddy R . Five-year outbreak of community- and hospital-acquired Mycobacterium porcinum infections related to public water supplies. J Clin Microbiol. 2011; 49(12):4231-8. PMC: 3232971. DOI: 10.1128/JCM.05122-11. View

5.
Schinsky M, Morey R, Steigerwalt A, Douglas M, Wilson R, Floyd M . Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and.... Int J Syst Evol Microbiol. 2004; 54(Pt 5):1653-1667. DOI: 10.1099/ijs.0.02743-0. View